Swissmedic met en garde contre la multiplication des offres de produits falsifis, trompeurs ou non autoriss destins la perte de poids et faisant rfrence aux principes actifs de type GLP-1
doi:10.1016/j.physbeh.2011.01.012 64
SeekPeptides built this resource because accurate dosing is not optional
Common reported side effects include nausea, vomiting, constipation, diarrhea, reduced appetite, and unusual skin sensations
That means compounded versions of semaglutide the active ingredient in Novo Nordisk's Ozempic and Rybelsus for diabetes and obesity therapy Wegovy are already in the market
The most important sub-groups reviewed include abnormal metabolic obesity, normal metabolic obesity, abnormal metabolic weight, normal metabolic weight, and sarcopenic obesity (3)